These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 2279767)
1. Differential effect of retinoic acid on ADP and collagen induced platelet aggregation. Mukherjee G; Chatterjee GC; Banerjee D; Bhattacharya DK Indian J Exp Biol; 1990 Oct; 28(10):949-52. PubMed ID: 2279767 [TBL] [Abstract][Full Text] [Related]
2. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
3. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439 [TBL] [Abstract][Full Text] [Related]
4. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation]. Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797 [TBL] [Abstract][Full Text] [Related]
5. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate. Nunn B Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides. Gollamudi R; Dillingham EO; Bond SE Blood Coagul Fibrinolysis; 1994 Jun; 5(3):375-83. PubMed ID: 8075309 [TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA). Chen R; Liang N Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966 [TBL] [Abstract][Full Text] [Related]
9. Effect of ketotifen and disodium cromoglycate on human platelet aggregation. García Mesa M; Arruzazabala Valmaña ML Allergol Immunopathol (Madr); 1989; 17(1):33-4. PubMed ID: 2502003 [TBL] [Abstract][Full Text] [Related]
10. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Pampuch A; Cerletti C; de Gaetano G Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371 [TBL] [Abstract][Full Text] [Related]
11. Effect of epinephrine on rapid ADP-induced aggregation, protein phosphorylation, and cytoplasmic calcium dynamics of platelets: a quenched-flow study. Carty DJ; Jones GD; Freas DL; Gear AR J Lab Clin Med; 1988 Nov; 112(5):603-11. PubMed ID: 3183492 [TBL] [Abstract][Full Text] [Related]
12. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets. Li BY; Bai Y; Li WH Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761 [TBL] [Abstract][Full Text] [Related]
14. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
15. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075 [TBL] [Abstract][Full Text] [Related]
16. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP. Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902 [TBL] [Abstract][Full Text] [Related]
17. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function. Natarajan P; May JA; Sanderson HM; Zabe M; Spangenberg P; Heptinstall S Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446 [TBL] [Abstract][Full Text] [Related]
18. Effects of endothelin-1 on aggregation of normal and uremic platelets. Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D. Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051 [TBL] [Abstract][Full Text] [Related]
20. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation. Matera C; Falzarano C; Vacca C; Falciani M; Rossi F J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]